{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:24:15Z","timestamp":1790774655702,"version":"4.1.0"},"reference-count":129,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2024,7,11]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>\n                    Left heart disease (LHD) is the most common cause of pulmonary hypertension (PH), which may be classified further as isolated post-capillary (ipcPH) or combined post- and pre-capillary PH (cpcPH). The 7th World Symposium on Pulmonary Hypertension PH-LHD task force reviewed newly reported randomised clinical trials and contemplated novel opportunities for improving outcome. Results from major randomised clinical trials reinforced prior recommendations against the use of pulmonary arterial hypertension therapy in PH-LHD outside of clinical trials, and suggested possible harm. Greater focus on phenotyping was viewed as one general strategy by which to ultimately improve clinical outcomes. This is potentially achievable by individualising ipcPH\n                    <jats:italic>versus<\/jats:italic>\n                    cpcPH diagnosis for patients with pulmonary arterial wedge pressure within a diagnostic grey zone (12\u201318\u2005mmHg), and through a newly developed PH-LHD staging system. In this model, PH accompanies LHD across four stages (A=at risk, B=structural heart disease, C=symptomatic heart disease, D=advanced), with each stage characterised by progression in clinical characteristics, haemodynamics and potential therapeutic strategies. Along these lines, the task force proposed disaggregating PH-LHD to emphasise specific subtypes for which PH prevalence, pathophysiology and treatment are unique. This includes re-interpreting mitral and aortic valve stenosis through a contemporary lens, and focusing on PH within the hypertrophic cardiomyopathy and amyloid cardiomyopathy clinical spectra. Furthermore, appreciating LHD in the profile of PH patients with chronic lung disease and chronic thromboembolic pulmonary disease is essential. However, engaging LHD patients in clinical research more broadly is likely to require novel methodologies such as pragmatic trials and may benefit from next-generation analytics to interpret results.\n                  <\/jats:p>","DOI":"10.1183\/13993003.01344-2024","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T05:25:20Z","timestamp":1724909120000},"page":"2401344","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":97,"title":["Pulmonary hypertension associated with left heart disease"],"prefix":"10.1183","volume":"64","author":[{"given":"Bradley A.","family":"Maron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Bortman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica H.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0485-2692","authenticated-orcid":false,"given":"Irene M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan H.","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Vachi\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Tedford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"2024112623054960000_64.4.2401344.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv512"},{"key":"2024112623054960000_64.4.2401344.2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001079"},{"key":"2024112623054960000_64.4.2401344.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.02.015"},{"key":"2024112623054960000_64.4.2401344.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.646166"},{"key":"2024112623054960000_64.4.2401344.5","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.jacc.2020.10.007","article-title":"Cardiopulmonary hemodynamics in pulmonary hypertension and heart failure: JACC review topic of the week","volume":"76","author":"Maron","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024112623054960000_64.4.2401344.6","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.116.022362","article-title":"Systemic consequences of pulmonary hypertension and right-sided heart failure","volume":"141","author":"Rosenkranz","year":"2000","journal-title":"Circulation"},{"key":"2024112623054960000_64.4.2401344.7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41569-022-00705-w","article-title":"The need for increased pragmatism in cardiovascular clinical trials","volume":"19","author":"Usman","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2024112623054960000_64.4.2401344.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018"},{"key":"2024112623054960000_64.4.2401344.9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00145608"},{"key":"2024112623054960000_64.4.2401344.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020207"},{"key":"2024112623054960000_64.4.2401344.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201706-1215OC"},{"key":"2024112623054960000_64.4.2401344.12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.chest.2022.09.040","article-title":"Evidence of advanced pulmonary vascular remodeling in obstructive hypertrophic cardiomyopathy with pulmonary hypertension","volume":"163","author":"Maron","year":"2023","journal-title":"Chest"},{"key":"2024112623054960000_64.4.2401344.13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/jamacardio.2019.3345","article-title":"Association of mild echocardiographic pulmonary hypertension with mortality and right ventricular function","volume":"4","author":"Huston","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2024112623054960000_64.4.2401344.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.482"},{"key":"2024112623054960000_64.4.2401344.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.031608"},{"key":"2024112623054960000_64.4.2401344.16","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30317-9"},{"key":"2024112623054960000_64.4.2401344.17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216476"},{"key":"2024112623054960000_64.4.2401344.18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022"},{"key":"2024112623054960000_64.4.2401344.19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac237"},{"key":"2024112623054960000_64.4.2401344.20","first-page":"3618","article-title":"Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study","volume":"43","author":"Fauvel","year":"2024","journal-title":"Eur Heart J"},{"key":"2024112623054960000_64.4.2401344.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201402-0269PP"},{"key":"2024112623054960000_64.4.2401344.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2012.01.024"},{"key":"2024112623054960000_64.4.2401344.23","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1513\/AnnalsATS.202303-216OC","article-title":"Impact of pulmonary hypertension hemodynamic classification based on the methodology used to measure pulmonary artery wedge pressure and cardiac output","volume":"20","author":"Sahay","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"2024112623054960000_64.4.2401344.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413687"},{"key":"2024112623054960000_64.4.2401344.25","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01886-2017"},{"key":"2024112623054960000_64.4.2401344.26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04625-2020"},{"key":"2024112623054960000_64.4.2401344.27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202402-0359VP"},{"key":"2024112623054960000_64.4.2401344.28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004436"},{"key":"2024112623054960000_64.4.2401344.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603693"},{"key":"2024112623054960000_64.4.2401344.30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12890-017-0549-5","article-title":"Prevalence and etiologies of pulmonary hypertension in Africa: a systematic review and meta-analysis","volume":"17","author":"Bigna","year":"2017","journal-title":"BMC Pulm Med"},{"key":"2024112623054960000_64.4.2401344.31","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.19.2.279"},{"key":"2024112623054960000_64.4.2401344.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00875-3"},{"key":"2024112623054960000_64.4.2401344.33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/2045-8932.114779","article-title":"Persistent pulmonary artery hypertension in patients undergoing balloon mitral valvotomy","volume":"3","author":"Nair","year":"2013","journal-title":"Pulm Circ"},{"key":"2024112623054960000_64.4.2401344.34","doi-asserted-by":"crossref","first-page":"e12140","DOI":"10.1002\/pul2.12140","article-title":"Prevalence and survival associated with pulmonary hypertension after mitral valve replacement: national echocardiography database of Australia study","volume":"12","author":"Collins","year":"2022","journal-title":"Pulm Circ"},{"key":"2024112623054960000_64.4.2401344.35","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.9.137"},{"key":"2024112623054960000_64.4.2401344.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.018"},{"key":"2024112623054960000_64.4.2401344.37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jtcvs.2016.02.038","article-title":"The impact of csoncomitant pulmonary hypertension on early and late outcomes following surgery for mitral stenosis","volume":"152","author":"Yang","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024112623054960000_64.4.2401344.38","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-322184"},{"key":"2024112623054960000_64.4.2401344.39","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs043"},{"key":"2024112623054960000_64.4.2401344.40","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1161\/CIRCULATIONAHA.117.033048","article-title":"Patients at intermediate surgical risk undergoing isolated interventional or surgical aortic valve implantation for severe symptomatic aortic valve stenosis","volume":"138","author":"Werner","year":"2018","journal-title":"Circulation"},{"key":"2024112623054960000_64.4.2401344.41","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.002253"},{"key":"2024112623054960000_64.4.2401344.42","doi-asserted-by":"crossref","first-page":"e008959","DOI":"10.1161\/CIRCINTERVENTIONS.120.008959","article-title":"Determinants and impact of heart failure readmission following transaortic valve replacement","volume":"13","author":"Auffret","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2024112623054960000_64.4.2401344.43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/heartjnl-2023-322881","article-title":"Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation","volume":"110","author":"Cardaioli","year":"2023","journal-title":"Heart"},{"key":"2024112623054960000_64.4.2401344.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2019.08.031"},{"key":"2024112623054960000_64.4.2401344.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114705"},{"key":"2024112623054960000_64.4.2401344.46","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jacc.2022.09.005","article-title":"Pulmonary hypertension and aortic stenosis: a piece of the puzzle","volume":"80","author":"G\u00e9n\u00e9reux","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024112623054960000_64.4.2401344.47","doi-asserted-by":"crossref","first-page":"e12249","DOI":"10.1002\/pul2.12249","article-title":"Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre- and postcapillary pulmonary hypertension","volume":"13","author":"Babu","year":"2023","journal-title":"Pulm Circ"},{"key":"2024112623054960000_64.4.2401344.48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009355"},{"key":"2024112623054960000_64.4.2401344.49","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2023-323473"},{"key":"2024112623054960000_64.4.2401344.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.11.052"},{"key":"2024112623054960000_64.4.2401344.51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ahj.2017.06.006","article-title":"Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: similarities and disparities","volume":"192","author":"Adir","year":"2017","journal-title":"Am Heart J"},{"key":"2024112623054960000_64.4.2401344.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2006.12.012"},{"key":"2024112623054960000_64.4.2401344.53","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.jacc.2021.09.1362","article-title":"Evolution of late right heart failure with left ventricular assist devices and association with outcomes","volume":"78","author":"Rame","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2024112623054960000_64.4.2401344.54","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001458"},{"key":"2024112623054960000_64.4.2401344.55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915928"},{"key":"2024112623054960000_64.4.2401344.56","first-page":"1497","article-title":"Vericiguat in heart failure with reduced ejection fraction","volume":"383","author":"Ryan","year":"2020","journal-title":"N Engl J Med"},{"key":"2024112623054960000_64.4.2401344.57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911303"},{"key":"2024112623054960000_64.4.2401344.58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206286"},{"key":"2024112623054960000_64.4.2401344.59","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"2024112623054960000_64.4.2401344.60","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.052503"},{"key":"2024112623054960000_64.4.2401344.61","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00392-021-01954-4","article-title":"SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure-further evidence for improved hemodynamics by continuous pressure monitoring","volume":"111","author":"Kirschbaum","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"2024112623054960000_64.4.2401344.62","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/ehf2.12850","article-title":"Effects of dapagliflozin on congestion assessed by remote pulmonary artery pressure monitoring","volume":"7","author":"Mullens","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2024112623054960000_64.4.2401344.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.02.032"},{"key":"2024112623054960000_64.4.2401344.64","doi-asserted-by":"crossref","first-page":"e0036989","DOI":"10.1161\/CIRCHEARTFAILURE.116.003689","article-title":"Mechanism of progressive heart failure and significance of pulmonary hypertension in obstructive hypertrophic cardiomyopathy","volume":"10","author":"Covella","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2024112623054960000_64.4.2401344.65","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.amjcard.2023.01.014","article-title":"Significance of pulmonary hypertension in cardiac amyloidosis","volume":"192","author":"Longinow","year":"2023","journal-title":"Am J Cardiol"},{"key":"2024112623054960000_64.4.2401344.66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805689"},{"key":"2024112623054960000_64.4.2401344.67","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2012.109"},{"key":"2024112623054960000_64.4.2401344.68","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000937"},{"key":"2024112623054960000_64.4.2401344.69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2021.09.040","article-title":"Outcomes over follow-up \u226510\u2005years after surgical myectomy for symptomatic obstructive hypertrophic cardiomyopathy","volume":"163","author":"Maron","year":"2022","journal-title":"Am J Cardiol"},{"key":"2024112623054960000_64.4.2401344.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.05.038"},{"key":"2024112623054960000_64.4.2401344.71","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00012408"},{"key":"2024112623054960000_64.4.2401344.72","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/eurheartj\/ehac205","article-title":"Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study","volume":"43","author":"Eckhardt","year":"2022","journal-title":"Eur Heart J"},{"key":"2024112623054960000_64.4.2401344.73","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacc.2022.11.049","article-title":"Left ventricular filling pressure in chronic thromboembolic pulmonary hypertension","volume":"81","author":"Gerges","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2024112623054960000_64.4.2401344.74","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.000091"},{"key":"2024112623054960000_64.4.2401344.75","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034646"},{"key":"2024112623054960000_64.4.2401344.76","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ejhf.1614","article-title":"Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fraction","volume":"22","author":"Barandiar\u00e1n Aizpurua","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2024112623054960000_64.4.2401344.77","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01897-2018"},{"key":"2024112623054960000_64.4.2401344.78","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.chest.2020.08.019","article-title":"A fluid challenge test for the diagnosis of occult heart failure","volume":"159","author":"D'Alto","year":"2021","journal-title":"Chest"},{"key":"2024112623054960000_64.4.2401344.79","doi-asserted-by":"crossref","first-page":"e008935","DOI":"10.1161\/CIRCHEARTFAILURE.121.008935","article-title":"The value of passive leg raise during right heart catheterization in diagnosing heart failure with preserved ejection fraction","volume":"15","author":"van de Bovenkamp","year":"2022","journal-title":"Circ Heart Fail"},{"key":"2024112623054960000_64.4.2401344.80","doi-asserted-by":"crossref","first-page":"e012504","DOI":"10.1161\/JAHA.119.012504","article-title":"Echocardiographic detection of occult diastolic dysfunction in pulmonary hypertension after fluid challenge","volume":"8","author":"Agrawal","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2024112623054960000_64.4.2401344.81","doi-asserted-by":"crossref","first-page":"2045894018819803","DOI":"10.1177\/2045894018819803","article-title":"Clinical and hemodynamic factors in predicting response to fluid challenge during right heart catheterization","volume":"9","author":"Moghaddam","year":"2019","journal-title":"Pulm Circ"},{"key":"2024112623054960000_64.4.2401344.82","doi-asserted-by":"crossref","first-page":"e007555","DOI":"10.1161\/CIRCHEARTFAILURE.120.007555","article-title":"Current limitations of invasive exercise hemodynamics for the diagnosis of heart failure with preserved ejection fraction","volume":"14","author":"Baratto","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2024112623054960000_64.4.2401344.83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.048"},{"key":"2024112623054960000_64.4.2401344.84","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ejhf.2747","article-title":"Central haemodynamic abnormalities and outcome in patients with unexplained dyspnoea","volume":"25","author":"Omote","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2024112623054960000_64.4.2401344.85","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00379-2023"},{"key":"2024112623054960000_64.4.2401344.86","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023839"},{"key":"2024112623054960000_64.4.2401344.87","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.cardfail.2023.06.009","article-title":"Variation in hemodynamic assessment and interpretation: a call to standardize the right heart catheterization","volume":"29","author":"Grinstein","year":"2023","journal-title":"J Card Fail"},{"key":"2024112623054960000_64.4.2401344.88","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.122.059486","article-title":"Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure","volume":"145","author":"Borlaug","year":"2022","journal-title":"Circulation"},{"key":"2024112623054960000_64.4.2401344.89","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jchf.2023.03.003","article-title":"Shedding light on latent pulmonary vascular disease in heart failure with preserved ejection fraction","volume":"11","author":"Caravita","year":"2023","journal-title":"JACC Heart Fail"},{"key":"2024112623054960000_64.4.2401344.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.09.062"},{"key":"2024112623054960000_64.4.2401344.91","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cardfail.2021.01.021","article-title":"Nonresponse to acute vasodilator challenge and prognosis in heart failure with pulmonary hypertension","volume":"8","author":"Ghio","year":"2021","journal-title":"J Card Fail"},{"key":"2024112623054960000_64.4.2401344.92","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.amjcard.2023.09.032","article-title":"Can inhaled nitric oxide response predict tolerance to therapies and survival in patients with combined precapillary and postcapillary pulmonary hypertension?","volume":"207","author":"Krishtopaytis","year":"2023","journal-title":"Am J Cardiol"},{"key":"2024112623054960000_64.4.2401344.93","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/eurheartj\/ehy331","article-title":"Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease","volume":"39","author":"Gorter","year":"2018","journal-title":"Eur Heart J"},{"key":"2024112623054960000_64.4.2401344.94","doi-asserted-by":"crossref","first-page":"10.1177_2045894020917887","DOI":"10.1177\/2045894020917887","article-title":"Exercise and fluid challenge during right heart catheterisation for evaluation of dyspnoea","volume":"10","author":"Ewert","year":"2020","journal-title":"Pulm Circ"},{"key":"2024112623054960000_64.4.2401344.95","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1513\/AnnalsATS.202201-077OC","article-title":"Hemodynamic responses to provocative maneuvers during right heart catheterization","volume":"19","author":"Montan\u00e9","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2024112623054960000_64.4.2401344.96","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2019.11.104","article-title":"Impact of saline loading at cardiac catheterization on the classification and management of patients evaluated for pulmonary hypertension","volume":"306","author":"Moghaddam","year":"2020","journal-title":"Int J Cardiol"},{"key":"2024112623054960000_64.4.2401344.97","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s00392-019-01531-w","article-title":"Passive leg-lifting in heart failure patients predicts exercise-induced rise in left ventricular filling pressures","volume":"109","author":"Tossavainen","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"2024112623054960000_64.4.2401344.98","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cardfail.2023.04.009","article-title":"Right heart adaptation to exercise in pulmonary hypertension: an invasive hemodynamic study","volume":"29","author":"Baratto","year":"2023","journal-title":"J Card Fail"},{"key":"2024112623054960000_64.4.2401344.99","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cardfail.2023.05.023","article-title":"Systemic arterial oxygen levels differentiate pre- and post-capillary predominant hemodynamic abnormalities during exercise in undifferentiated dyspnea on exertion","volume":"30","author":"Hardin","year":"2024","journal-title":"J Card Fail"},{"key":"2024112623054960000_64.4.2401344.100","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.echo.2023.07.010","article-title":"Lung ultrasound, echocardiography, and fluid challenge for the differential diagnosis of pulmonary hypertension","volume":"36","author":"D'Alto","year":"2023","journal-title":"J Am Soc Echocardiogr"},{"key":"2024112623054960000_64.4.2401344.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.05.047"},{"key":"2024112623054960000_64.4.2401344.102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.07.068"},{"key":"2024112623054960000_64.4.2401344.103","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/2045893217700438","article-title":"Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction","volume":"7","author":"Bourji","year":"2017","journal-title":"Pulm Circ"},{"key":"2024112623054960000_64.4.2401344.104","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00091212"},{"key":"2024112623054960000_64.4.2401344.105","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/s41598-022-06400-7","article-title":"High prevalence of occult left ventricular diastolic dysfunction detected by exercise stress test in systemic sclerosis","volume":"12","author":"Mohri","year":"2022","journal-title":"Sci Rep"},{"key":"2024112623054960000_64.4.2401344.106","first-page":"2045894018816089","article-title":"Hemodynamic changes after acute fluid loading in patients with systemic sclerosis without pulmonary hypertension","volume":"9","author":"D'Alto","year":"2019","journal-title":"Pulm Circ"},{"key":"2024112623054960000_64.4.2401344.107","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216274"},{"key":"2024112623054960000_64.4.2401344.108","doi-asserted-by":"crossref","first-page":"00229-2023","DOI":"10.1183\/23120541.00229-2023","article-title":"Machine learning to differentiate pulmonary hypertension due to left heart disease from pulmonary arterial hypertension","volume":"9","author":"Swinnen","year":"2023","journal-title":"ERJ Open Res"},{"key":"2024112623054960000_64.4.2401344.109","doi-asserted-by":"crossref","first-page":"e030025","DOI":"10.1161\/JAHA.123.030025","article-title":"Right ventricular-vascular uncoupling predicts pulmonary hypertension in clinically diagnosed heart failure with preserved ejection fraction","volume":"13","author":"Chen","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2024112623054960000_64.4.2401344.110","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jacc.2022.07.011","article-title":"Heart failure with preserved ejection fraction as an exercise deficiency syndrome: JACC Focus Seminar 2\/4","volume":"80","author":"La Gerche","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024112623054960000_64.4.2401344.111","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.039136"},{"key":"2024112623054960000_64.4.2401344.112","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2024112623054960000_64.4.2401344.113","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jchf.2021.01.015","article-title":"Levosimendan improves hemodynamics and exercise tolerance in PH-HFpEF: results of the randomized placebo-controlled HELP trial","volume":"9","author":"Burkoff","year":"2021","journal-title":"JACC Heart Fail"},{"key":"2024112623054960000_64.4.2401344.114","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1093\/eurheartj\/ehac389","article-title":"Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial","volume":"43","author":"Dachs","year":"2022","journal-title":"Eur Heart J"},{"key":"2024112623054960000_64.4.2401344.115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ejhf.2745","article-title":"\u03b23 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial","volume":"25","author":"Garc\u00eda-\u00c1lvarez","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2024112623054960000_64.4.2401344.116","unstructured":"Voors A . SERENADE: Macitentan in Heart Failure with preSERved ejEction fractioN and pulmonAry Vascular DiseasE. Presented at the European Society of Cardiology on 21 May 2022; Barcelona, Spain. https:\/\/esc365.escardio.org\/presentation\/250300."},{"key":"2024112623054960000_64.4.2401344.117","first-page":"600","article-title":"Tadalafil for treatment of combined postcapillary and precapillary pulmonary hypertension in patients with heart failure and preserved ejection fraction: a randomized controlled phase 3 study","volume":"150","author":"Hoeper","year":"2024","journal-title":"Circulation"},{"key":"2024112623054960000_64.4.2401344.118","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007264"},{"key":"2024112623054960000_64.4.2401344.119","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1164\/rccm.202211-2097OC","article-title":"Elevated pulmonary arterial compliance is associated with survival in pulmonary hypertension: results from a novel network medicine analysis","volume":"208","author":"Wang","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2024112623054960000_64.4.2401344.120","first-page":"e0299667","article-title":"iCPET calculator: a web-based application to standardize the calculation of alpha distensibility in patients with pulmonary arterial hypertension","volume":"12","author":"Eliott","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2024112623054960000_64.4.2401344.121","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510063"},{"key":"2024112623054960000_64.4.2401344.122","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1017-7"},{"key":"2024112623054960000_64.4.2401344.123","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510059"},{"key":"2024112623054960000_64.4.2401344.124","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"2024112623054960000_64.4.2401344.125","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02076-1"},{"key":"2024112623054960000_64.4.2401344.126","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.052318"},{"key":"2024112623054960000_64.4.2401344.127","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.2020"},{"key":"2024112623054960000_64.4.2401344.128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.10.022"},{"key":"2024112623054960000_64.4.2401344.129","doi-asserted-by":"crossref","first-page":"e015089","DOI":"10.1161\/CIRCIMAGING.122.015089","article-title":"Atrial dysfunction in significant atrial functional mitral regurgitation: phenotypes and prognostic implications","volume":"16","author":"Cramariuc","year":"2023","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01344-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T02:22:19Z","timestamp":1740363739000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01344-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":129,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,10,31]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1183\/13993003.01344-2024"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01344-2024","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}